Arecor Therapeutics plc (AIM: AREC)
80.00
+2.50 (3.23%)
Sep 11, 2024, 3:12 PM GMT+1
Arecor Therapeutics Balance Sheet
Financials in millions GBP. Fiscal year is January - December.
Millions GBP. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2017 |
---|---|---|---|---|---|---|---|
Period Ending | Dec '23 Dec 31, 2023 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2017 |
Cash & Equivalents | 5.09 | 5.09 | 4.77 | 18.32 | 2.9 | 3.07 | Upgrade
|
Short-Term Investments | 1.66 | 1.66 | 8.04 | - | - | - | Upgrade
|
Cash & Short-Term Investments | 6.75 | 6.75 | 12.81 | 18.32 | 2.9 | 3.07 | Upgrade
|
Cash Growth | -47.27% | -47.27% | -30.08% | 532.02% | -5.72% | -10.83% | Upgrade
|
Accounts Receivable | 2.27 | 2.27 | 0.66 | 0.71 | 0.08 | 0.5 | Upgrade
|
Other Receivables | 1.06 | 1.06 | 2.16 | 0.86 | 0.78 | 0.31 | Upgrade
|
Receivables | 3.32 | 3.32 | 2.82 | 1.57 | 0.86 | 0.81 | Upgrade
|
Inventory | 0.77 | 0.77 | 1.13 | - | - | - | Upgrade
|
Prepaid Expenses | 0.32 | 0.32 | 0.72 | 0.63 | 0.06 | 0.03 | Upgrade
|
Total Current Assets | 11.17 | 11.17 | 17.48 | 20.52 | 3.82 | 3.92 | Upgrade
|
Property, Plant & Equipment | 0.83 | 0.83 | 0.84 | 0.33 | 0.38 | 0.3 | Upgrade
|
Goodwill | 1.48 | 1.48 | 1.48 | - | - | - | Upgrade
|
Other Intangible Assets | 1.81 | 1.81 | 1.92 | 0.03 | 0.04 | 0.05 | Upgrade
|
Other Long-Term Assets | 0.08 | 0.08 | 0.05 | 0.05 | 0.05 | 0.05 | Upgrade
|
Total Assets | 15.38 | 15.38 | 21.77 | 20.92 | 4.28 | 4.31 | Upgrade
|
Accounts Payable | 2.25 | 2.25 | 1.71 | 0.52 | 0.47 | 0.37 | Upgrade
|
Accrued Expenses | 2.13 | 2.13 | 1.27 | 1.17 | 0.69 | 0.27 | Upgrade
|
Current Portion of Leases | 0.12 | 0.12 | 0.2 | 0.13 | 0.11 | 0.1 | Upgrade
|
Current Income Taxes Payable | 0.1 | 0.1 | 0.12 | 0.09 | 0.05 | 0.05 | Upgrade
|
Current Unearned Revenue | 0.23 | 0.23 | 0.21 | 0.35 | 0.08 | 0.24 | Upgrade
|
Other Current Liabilities | 0.32 | 0.32 | 0.22 | 0.02 | 0.02 | 0.02 | Upgrade
|
Total Current Liabilities | 5.15 | 5.15 | 3.73 | 2.27 | 1.41 | 1.04 | Upgrade
|
Long-Term Debt | - | - | - | - | 1.7 | - | Upgrade
|
Long-Term Leases | 0.22 | 0.22 | 0.09 | 0.11 | 0.19 | 0.06 | Upgrade
|
Long-Term Deferred Tax Liabilities | 0.45 | 0.45 | 0.5 | - | - | - | Upgrade
|
Other Long-Term Liabilities | 0.03 | 0.03 | - | - | 0.21 | - | Upgrade
|
Total Liabilities | 5.85 | 5.85 | 4.31 | 2.37 | 3.51 | 1.1 | Upgrade
|
Common Stock | 0.31 | 0.31 | 0.31 | 0.28 | 0.03 | 0.03 | Upgrade
|
Additional Paid-In Capital | 28.98 | 28.98 | 28.98 | 23.35 | 11.59 | 11.59 | Upgrade
|
Retained Earnings | -34.72 | -34.72 | -26.18 | -17.05 | -11.89 | -9.14 | Upgrade
|
Comprensive Income & Other | 14.97 | 14.97 | 14.35 | 11.97 | 1.05 | 0.73 | Upgrade
|
Shareholders' Equity | 9.53 | 9.53 | 17.46 | 18.55 | 0.77 | 3.21 | Upgrade
|
Total Liabilities & Equity | 15.38 | 15.38 | 21.77 | 20.92 | 4.28 | 4.31 | Upgrade
|
Total Debt | 0.34 | 0.34 | 0.29 | 0.23 | 2 | 0.16 | Upgrade
|
Net Cash (Debt) | 6.41 | 6.41 | 12.52 | 18.09 | 0.9 | 2.92 | Upgrade
|
Net Cash Growth | -48.76% | -48.76% | -30.78% | 1902.77% | -69.03% | -9.61% | Upgrade
|
Net Cash Per Share | 0.21 | 0.21 | 0.43 | 0.79 | 0.06 | 0.18 | Upgrade
|
Filing Date Shares Outstanding | 30.63 | 30.63 | 30.62 | 27.84 | 27.68 | 15.77 | Upgrade
|
Total Common Shares Outstanding | 30.63 | 30.63 | 30.62 | 27.84 | 16.29 | 15.77 | Upgrade
|
Working Capital | 6.02 | 6.02 | 13.75 | 18.25 | 2.41 | 2.88 | Upgrade
|
Book Value Per Share | 0.31 | 0.31 | 0.57 | 0.67 | 0.05 | 0.20 | Upgrade
|
Tangible Book Value | 6.23 | 6.23 | 14.05 | 18.52 | 0.74 | 3.16 | Upgrade
|
Tangible Book Value Per Share | 0.20 | 0.20 | 0.46 | 0.67 | 0.05 | 0.20 | Upgrade
|
Machinery | 1.18 | 1.18 | 1.17 | 0.76 | 0.71 | 0.67 | Upgrade
|
Leasehold Improvements | 0.14 | 0.14 | 0.1 | 0.08 | 0.08 | 0.08 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.